Johnson & Johnson (JNJ) – ETFs
-
Consumer Staples Sector Outperforms, ETF (XLP) Climbs 1.25%
-
Wall Street ends higher with boost from big tech
-
Wall Street jumps as hopes for easing lockdown offset earnings worry
-
Wall Street rallies, led by healthcare jump
-
S&P closes at record on Fed bump
-
Strong tech results propel S&P 500, Nasdaq
-
Boeing, J&J, dismal China data drag Wall Street lower
-
Wall Street gains as earnings season begins in earnest
-
Stocks pause on unsettled trade deal; earnings eyed
-
Wall Street gains on trade optimism, but Beijing tempers hopes
-
Wall Street slips as bank earnings, Trump trade comments weigh
-
Wall St. notches all-time highs on lingering rate-cut optimism
-
S&P flat as government shutdown threat, Fed decision loom
-
Wall St. tumbles on global growth worries, J&J decline
-
Wall St. climbs on Powell comments, earnings
-
S&P 500 caps off strongest week in five years
-
Goldman Sachs, J&J pull Wall Street lower
-
Celgene (CELG), Related Stocks Decline Amid Biopharma Weakness
-
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
-
S&P 500 (SPY) is Going Higher Because Analyst Carter Worth Says So
-
Pfizer (PFE) Drags on XLV ETF
-
Notable ETF Movers of the Day 04/17: (QQQ) (USO) (TAN) Higher; (VXX) (GLD) Lower
-
Notable ETF Movers of the Day 01/25: EWJ, UUP VXX Higher; UNG, GLD, MOO Lower
Back to JNJ Stock Lookup